FdaApplication
ANDA 216995
Identifiers
- fda_app_no: ANDA216995
Properties
| Property | Value |
|---|---|
| applicant_name | AIPING PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2025-05-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIVAROXABAN | RIVAROXABAN | 10MG | TABLET;ORAL |
| RIVAROXABAN | RIVAROXABAN | 15MG | TABLET;ORAL |
| RIVAROXABAN | RIVAROXABAN | 20MG | TABLET;ORAL |
3 products